Expression of concern to "Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study" [EJOG 165(2) (2012) 254-258].

Autor: Shaltout A; Dr. Samir Abbas Medical Center, Jeddah, Saudi Arabia; Department of Obstetrics & Gynaecology, Faculty of Medicine, Cairo University, Egypt., Shohyab A; Dr. Samir Abbas Medical Center, Jeddah, Saudi Arabia; Department of Obstetrics & Gynaecology, Faculty of Medicine, Cairo University, Egypt., Youssef MAFM; Department of Obstetrics & Gynaecology, Faculty of Medicine, Cairo University, Egypt; Egyptian International Fertility Center-IVF (EIFC-IVF), Cairo, Egypt. Electronic address: mohamedyoussef1973@gmail.com.

Publikováno v: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Aug; Vol. 299, pp. 302. Date of Electronic Publication: 2024 Jun 07.

Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study

Autor: Shaltout, Amany, Shohyab, Amal, Youssef, Mohamed A.F.M.

Publikováno v: In European Journal of Obstetrics and Gynecology December 2012 165(2):254-258

Efficacy of Local N‐Acetylcysteine Administration in Mitigating OHSS Parameters: A Comparative Analysis With Dopaminergic Agonist in the OHSS Model.

Autor: Letras-Luna, Dulce Elena¹ (AUTHOR), Rosas-Murrieta, Nora Hilda² (AUTHOR), Pazos-Salazar, Nidia Gary³ (AUTHOR), Flores-Hernández, Jorge⁴ (AUTHOR), Castelán, Francisco^5,6 (AUTHOR), Venegas, Berenice⁷ (AUTHOR), Díaz, Alfonso⁴ (AUTHOR), Treviño, Samuel⁸ (AUTHOR), Juárez-Serrano, Daniel⁹ (AUTHOR), García-Suastegui, Wendy Argelia¹ (AUTHOR), Handal-Silva, Anabella¹ (AUTHOR), Morán-Perales, José Luis¹ (AUTHOR) joseluis.moran@correo.buap.mx, Kotula Balak, Malgorzata (AUTHOR)

Publikováno v: International Journal of Endocrinology. 12/5/2024, Vol. 2024, p1-15. 15p.

Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome.

Autor: O'Brien, Travis J.¹ phmtjo@gwu.edu, Harralson, Arthur F.^1,2 AHarrals@su.edu, Tran, Tuyen³ ttran@childrensnational.org, Gindoff, Ian¹ ijgindoff@gmail.com, Orkunoglu-Suer, Funda E.⁴ Funda.E.Suer@questdiagnostics.com, Frankfurter, David⁵ dfrankfurter@mfa.gwu.edu, Gindoff, Paul⁵ pgindoff@email.gwu.edu

Publikováno v: Reproductive Biology & Endocrinology. 2014, Vol. 12 Issue 1, p1-17. 17p.

Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis.

Autor: Guo, Jun-Liang, Zhang, Duo-Duo, Zhao, Yue¹, Zhang, Dan², Zhang, Xi-Meng¹, Zhou, Can-Quan², Yao, Shu-Zhong²

Publikováno v: Scientific Reports. 1/15/2016, p19093. 1p.